Drugs Online » Prescription Drugs 17 » Vergo Generic Betahistine
IndicationsMeniere's Syndrome as defined by the following core symptoms:vertigo (with nausea/vomiting) hearing loss (hardness of hearing) tinnitus Dosage and AdministrationThe usual adult initial dose is 8 mg three to four times daily later reduced to 8 to 16 mg daily for maintenance depending on patient response. The maximum recommended daily dosage is 32 mg.The dosage should be individually adapted according to the response. Improvement can sometimes only be observed after a couple of weeks of treatment.
Buy Vergo Generic Betahistine and other Prescription Drugs 17 products online
at Medstore.
Buy Online at Medstore - Click Here!

About Vergo Generic Betahistine:
Product Type: Prescription Drugs 17
Vergo ( Generic Betahistine )
Vergo (Generic Betahistine)
Generic Betahistine
16mg
Generic Betahistine Vergo

View more
Prescription Drugs 17
Previous Product Next Product
Drugs Online:
From Gulf News: Runners should avoid prescription drugs. Statins may increase production of the enzyme creatine kinase, and hence heighten chances of muscle damage in athletes. Marathon running has increased in popularity over the past three decades, with participation in the United States rising from 25,000 runners in 1976 to nearly 470,000 in 2008. Many professional and recreational runners take prescription drugs, unaware of potential side-effects that affect runners in particular. One such class of drugs, called statins, which includes medicines such as Lipitor, Crestor and Pravachol, lowers blood cholesterol by inhibiting a cholesterol-producing enzyme and may even lower the risks of heart attack and further cardiovascular disease in a narrow category of patients. A new study forthcoming in the American Journal of Cardiology examined the effect of statins on creatine kinase (CK), an enzyme linked to muscle damage. Elevated levels of CK in the blood and muscle after exercise correlates with muscle damage. The study, conducted by Dr Beth Parker of the Henry Low Heart Centre at Connecticut's Hartford Hospital, is the first to measure CK levels in athletes taking statins after physical activity in a real-life environment rather than in a university laboratory.


|